CN103933437A - Traditional Chinese medicine composition for treating asthma and preparation method for same - Google Patents
Traditional Chinese medicine composition for treating asthma and preparation method for same Download PDFInfo
- Publication number
- CN103933437A CN103933437A CN201410162808.XA CN201410162808A CN103933437A CN 103933437 A CN103933437 A CN 103933437A CN 201410162808 A CN201410162808 A CN 201410162808A CN 103933437 A CN103933437 A CN 103933437A
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- chinese medicine
- medicine composition
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention provides a traditional Chinese medicine composition for treating asthma. The traditional Chinese medicine composition for treating asthma is prepared from liquorice, immature bitter orange, prepared rehmannia glutinosa, blackberry lily, radix scutellariae, cimicifugae foetidae, angelica sinensis, bulbus fritillariae cirrhosae, Chinese yam, rhizoma alismatis, radix stemonae, radices trichosanthis, fructus perillae, flos daturae, semen brassicae, schisandra chinensis, poria cocos and radix scrophulariae. The traditional Chinese medicine composition for treating asthma provided by the invention is low in toxic and side effects, and high in radical treatment efficiency. The traditional Chinese medicine composition for treating asthma is mainly used for treating and preventing symptoms such as dyspnea, cough, excessive phlegm, difficulty to lie on the back due to laboured breathing, and difficult breathing occurring in patients with asthma, and has a remarkable effect on years of asthma.
Description
Technical field
The invention belongs to the field of Chinese medicines, relate in particular to a kind of Chinese medicine composition for the treatment of asthma and preparation method thereof.
Background technology
Asthma is one of disease being difficult in the world today radical cure, it is the frequently-occurring disease of respiratory system, because trachea is to the hypersusceptible reaction of stimulus object, serious patient can continue a few days or outbreak several weeks, this disease has the features such as large to human health damage, sickness rate is high, the course of disease is long, to patient, has brought great misery and trouble.The treatment of existing asthma adopts Chinese and Western combination more, and its medicine adopts aminophylline, ephedrine, diphenhydramine and antibiotics more, though can temporarily control the state of an illness, easily recurrence, and have larger side effect; Conventional Chinese patent medicine capsule of antipyretics for lung, Bulbus Fritillariae Cirrhosae sheet etc., its slow curative effect, the course for the treatment of is long, and actual therapeutic effect is not fairly obvious.
Summary of the invention
The present invention overcomes the deficiencies in the prior art, provides as solving the problems of the technologies described above, and the Chinese medicine composition that a kind of preparation technology is simple, curative effect is fast, cure rate is high is provided.
The technical solution used in the present invention is: a kind of Chinese medicine composition for the treatment of asthma, it is characterized in that, and described preparation is prepared from by the crude drug of following weight proportion: Radix Glycyrrhizae 30-55 part; Fructus Aurantii Immaturus 15-35 part; Radix Rehmanniae Preparata 15-35 part; Rhizoma Belamcandae 30-40 part; Radix Scutellariae 30-45 part; Rhizoma Cimicifugae 22-40 part; Radix Angelicae Sinensis 30-40 part; Bulbus Fritillariae Cirrhosae 10-20 part; Rhizoma Dioscoreae 15-35 part; Rhizoma Alismatis 20-30 part; Radix Stemonae 20-35 part; Radix Trichosanthis 25-35 part; Fructus Perillae 5-8 part; Flos Daturae 1-3 part; Semen Sinapis Albae 20-30 part; Fructus Schisandrae Chinensis 35-45 part; Poria 20-30 part; Radix Scrophulariae 8-20 part.
Preferably, described Chinese medicine composition is prepared from by the crude drug of following weight proportion: Radix Glycyrrhizae 35-55 part; Fructus Aurantii Immaturus 25-35 part; Radix Rehmanniae Preparata 15-35 part; Rhizoma Belamcandae 30-40 part; Radix Scutellariae 30-45 part; Rhizoma Cimicifugae 30-40 part; Radix Angelicae Sinensis 30-40 part; Bulbus Fritillariae Cirrhosae 10-20 part; Rhizoma Dioscoreae 15-35 part; Rhizoma Alismatis 20-30 part; Radix Stemonae 20-35 part; Radix Trichosanthis 25-35 part; Fructus Perillae 5-8 part; Flos Daturae 1-3 part; Semen Sinapis Albae 20-30 part; Fructus Schisandrae Chinensis 35-45 part; Poria 20-30 part; Radix Scrophulariae 8-20 part.
Preferably, described Chinese medicine composition is prepared from by the crude drug of following weight proportion: Radix Glycyrrhizae 30-50 part; Fructus Aurantii Immaturus 12-25 part; Radix Rehmanniae Preparata 15-35 part; Rhizoma Belamcandae 35-45 part; Radix Scutellariae 30-45 part; Rhizoma Cimicifugae 22-28 part; Radix Angelicae Sinensis 30-40 part; Bulbus Fritillariae Cirrhosae 10-20 part; Rhizoma Dioscoreae 18-30 part; Rhizoma Alismatis 20-30 part; Radix Stemonae 20-35 part; Radix Trichosanthis 25-35 part; Fructus Perillae 5-8 part; Flos Daturae 1-3 part; Semen Sinapis Albae 20-30 part; Fructus Schisandrae Chinensis 35-45 part; Poria 20-30 part; Radix Scrophulariae 8-20 part.
Further, described Chinese medicine composition is prepared from by the crude drug of following weight proportion: 50 parts, Radix Glycyrrhizae; 25 parts of Fructus Aurantii Immaturuss; 30 parts, Radix Rehmanniae Preparata; 45 parts of Rhizoma Belamcandae; 30 parts of Radix Scutellariae; 25 parts of Rhizoma Cimicifugaes; 40 parts of Radix Angelicae Sinensis; 10 parts of Bulbus Fritillariae Cirrhosae; 30 parts of Rhizoma Dioscoreaes; 30 parts of Rhizoma Alismatis; 20 parts of the Radixs Stemonae; 25 parts of Radix Trichosanthis; 5 parts of Fructus Perillaes; 1 part of Flos Daturae; 30 parts of Semen Sinapis Albaes; 35 parts of Fructus Schisandrae Chinensis; 20 parts, Poria; 12 parts of Radix Scrophulariaes.
Chinese medicine composition of the present invention can be the various conventional extract oral medicine dosage form that contains or do not contain pharmaceutic adjuvant.As tablet, granule, pill, water decoction or capsule.
Another object of the present invention is to provide a kind of preparation method for the treatment of the Chinese medicine composition of asthma: by formula proportion, take each herbal medicine, each component is washed respectively, in temperature, be sterilizing 40-45 minute under 100 ℃, the condition of normal pressure, then be crushed to 100 object fine powders, mix.
The outstanding good effect of this medicine is low toxic and side effects, and radical cure efficiency is high.Out of breath, cough, the abundant expectoration that is mainly used in that asthma patient occurs, feeling suffocated is difficult to treatment and the control of the symptoms such as flat sleeping, dyspnea, and asthma for many years is also had to significant effect.Each crude drug effect is as follows: Radix Glycyrrhizae: invigorating the spleen and replenishing QI, and heat-clearing and toxic substances removing, expelling phlegm for arresting cough, relieving spasm to stop pain, neutralizes all medicines; Radix Rehmanniae Preparata: nourishing YIN and supplementing blood, beneficial essence is filled out marrow; Rhizoma Belamcandae: heat-clearing and toxic substances removing, expectorant, sore-throat relieving; Radix Scutellariae: heat clearing and damp drying, eliminating fire and detoxication; Rhizoma Cimicifugae: deliver rash, heat-clearing and toxic substances removing, elevate a turnable ladder yang-energy; Radix Angelicae Sinensis: enrich blood and invigorate blood circulation; Bulbus Fritillariae Cirrhosae: relieving cough and resolving phlegm, lung moistening; Rhizoma Dioscoreae: invigorating spleen and reinforcing stomach, kidney nourishing and replenishing vital essence; The Radix Stemonae: expectorant cough suppressant and anti-asthmatic has nourishing the lung to arrest cough; Radix Trichosanthis: clearing away heat-fire, promoting the production of body fluid to quench thirst, evacuation of pus detumescence; Flos Daturae: relieving asthma and cough, dispel the wind, narcotic analgesic, spasmolytic is only jerked and is controlled asthma.Semen Sinapis Albae: warming the interior apophlegmatisant, its property is wandered away, and can open lung qi dispersing gas, thoroughly reaches meridians, Fructus Schisandrae Chinensis: hold back astringent or styptic treatment for spontaneous sweating, supplementing QI for promoting the production of body fluid, kidney calming.Poria: wet detumescence, invigorating spleen to remove dampness, tranquilizing by nourishing the heart, Radix Scrophulariae: hot removing heat from blood, removing toxic substances, eliminating stagnation sore-throat relieving, the effect of YIN nourishing.By the coordinated of each crude drug, play the effect of clearing away heat-damp and promoting diuresis, preventing phlegm from forming and stopping coughing, resolving toxin and disinhibiting the throat, fundamentally solved asthma reason, reach the object of radical cure.
The specific embodiment
Embodiment 1:
50 parts, Radix Glycyrrhizae; 25 parts of Fructus Aurantii Immaturuss; 30 parts, Radix Rehmanniae Preparata; 45 parts of Rhizoma Belamcandae; 30 parts of Radix Scutellariae; 25 parts of Rhizoma Cimicifugaes; 40 parts of Radix Angelicae Sinensis; 10 parts of Bulbus Fritillariae Cirrhosae; 30 parts of Rhizoma Dioscoreaes; 30 parts of Rhizoma Alismatis; 20 parts of the Radixs Stemonae; 25 parts of Radix Trichosanthis; 5 parts of Fructus Perillaes; 1 part of Flos Daturae; 30 parts of Semen Sinapis Albaes; 35 parts of Fructus Schisandrae Chinensis; 20 parts, Poria; 12 parts of Radix Scrophulariaes.
Preparation method: take each herbal medicine by formula proportion, each component is washed respectively, be sterilizing 40-45 minute under 100 ℃, the condition of normal pressure in temperature, then be crushed to 100 object fine powders, mix.
Embodiment 2:
35 parts, Radix Glycyrrhizae; 30 parts of Fructus Aurantii Immaturuss; 25 parts, Radix Rehmanniae Preparata; 35 parts of Rhizoma Belamcandae; 40 parts of Radix Scutellariae; 40 parts of Rhizoma Cimicifugaes; 40 parts of Radix Angelicae Sinensis; 20 parts of Bulbus Fritillariae Cirrhosae; 20 parts of Rhizoma Dioscoreaes; 25 parts of Rhizoma Alismatis; 30 parts of the Radixs Stemonae; 30 parts of Radix Trichosanthis; 8 parts of Fructus Perillaes; 2 parts of Flos Daturaes; 30 parts of Semen Sinapis Albaes; 40 parts of Fructus Schisandrae Chinensis; 20 parts, Poria; 15 parts of Radix Scrophulariaes.
Preparation method is with embodiment 1.
Embodiment 3:
45 parts, Radix Glycyrrhizae; 20 parts of Fructus Aurantii Immaturuss; 30 parts, Radix Rehmanniae Preparata; 45 parts of Rhizoma Belamcandae; 40 parts of Radix Scutellariae; 25 parts of Rhizoma Cimicifugaes; 40 parts of Radix Angelicae Sinensis; 15 parts of Bulbus Fritillariae Cirrhosae; 20 parts of Rhizoma Dioscoreaes; 25 parts of Rhizoma Alismatis; 20 parts of the Radixs Stemonae; 25 parts of Radix Trichosanthis; 7 parts of Fructus Perillaes; 1 part of Flos Daturae; 30 parts of Semen Sinapis Albaes; 35 parts of Fructus Schisandrae Chinensis; 20 parts, Poria; 12 parts of Radix Scrophulariaes.
Preparation method is with embodiment 1.
Effect test
Usage and dosage: Chinese medicine composition of the present invention is made to capsule preparations according to a conventional method, every day 2-3 time, each 3.
In the 150 routine patients through curing with this prescription, male 80 examples wherein, female's 70 examples, the oldest 75 years old, minimum 8 years old, the course of disease was the shortest 6 months, the longest 20 years.
1. curative effect judgement:
Effective: the Severe Asthma symptoms such as patient is uncomfortable in chest, chest pain, dyspnea are alleviated completely, have once in a while slight outbreak only with mild such as coughs, do not need medication;
Effective: during patient's asthma attack, symptom obviously alleviates, and attack times also reduces to some extent;
Invalid: after medication, patient's symptoms of asthma is without alleviating.
2. therapeutic outcome
Two weeks rear therapeutic outcome statistics of patient's continuous use see the following form:
3. model case:
Case 1: Lee, man 25 years old, workman.Within 3 years old, suffer from asthma, clinical manifestation be out of breath, cough, have thick sputum, especially winter serious, flu very easily at ordinary times, incapability of work, slightly critical just anxious breathe heavily more than.Ring sound is obvious, once repeatedly uses additive method treatment, has no effect, within 18 years old, takes this medicine, every day 2 times, uses continuously one week rear first meeting effect of medicine of the present invention, uses two weeks afterwards without phenomenon out of breath, and cough alleviates, and uses be continuously almost recovered February.Can play now whole football.Seldom catch a cold.
Case 2: Song, female 51 years old, suffers from a heart complaint and asthma 4 years, clinical manifestation dyspnea, palpitation and short breath, angina pectoris, can hear wheezing sound in lung, weak all over, dare not move at ordinary times, weather conversion symptom increases the weight of, and once repeatedly uses additive method treatment, has no effect.Take angina then and there for this medicine, every day 2 times afterwards, use continuously medicine of the present invention first meeting effect after a week, uses two weeks rear nothings phenomenon of panting, cough alleviates, and uses be continuously almost recovered March.Can on a gas, not breathe heavily for 4th floors now.
Case 3: Zheng, man 15 years old, ill 2 years, suffers from pneumonia, bronchial asthma, regular flu, activity is breathed heavily, and breathes heavily and has expectorant, monthly outbreak repeatedly, take this medicine after three weeks, the state of an illness substantially improves and controls, and continues to take state of an illness rehabilitation after 2 months, from the not recurrence in 2 years till now of taking medicine.
Case 4: field, female 65 years old, ill 6 years, cough ant phlegm, uncomfortable in chest, breathe hard, dyspnea.Once repeatedly used other drug not reach promising result, after 3 weeks, took effect, breathed slightly smooth and easyly, after 4 weeks, greatly took a turn for the better, cough, expectorant obviously reduce, and during breathing, can not feel sensation of oppression over the chest with shortness of breath, after 10 weeks, and cough once in a while, expectorant disappears, and no longer feels uncomfortable in chest, breathes hard, but be unfit to do vigorous exercise during breathing, cures.After 1 year, visit, have no recurrence.
Above several embodiments of the present invention are had been described in detail, but described content is only preferred embodiment of the present invention, can not be considered to for limiting practical range of the present invention.All equalization variations of doing according to the present patent application scope and improvement etc., within all should still belonging to patent covering scope of the present invention.
Claims (7)
1. a Chinese medicine composition for the treatment of asthma, is characterized in that, described Chinese medicine composition is prepared from by the crude drug of following weight proportion: Radix Glycyrrhizae 30-55 part; Fructus Aurantii Immaturus 15-35 part; Radix Rehmanniae Preparata 15-35 part; Rhizoma Belamcandae 30-40 part; Radix Scutellariae 30-45 part; Rhizoma Cimicifugae 22-40 part; Radix Angelicae Sinensis 30-40 part; Bulbus Fritillariae Cirrhosae 10-20 part; Rhizoma Dioscoreae 15-35 part; Rhizoma Alismatis 20-30 part; Radix Stemonae 20-35 part; Radix Trichosanthis 25-35 part; Fructus Perillae 5-8 part; Flos Daturae 1-3 part; Semen Sinapis Albae 20-30 part; Fructus Schisandrae Chinensis 35-45 part; Poria 20-30 part; Radix Scrophulariae 8-20 part.
2. Chinese medicine composition according to claim 1, is characterized in that, described Chinese medicine composition is prepared from by the crude drug of following weight proportion: Radix Glycyrrhizae 35-55 part; Fructus Aurantii Immaturus 25-35 part; Radix Rehmanniae Preparata 15-35 part; Rhizoma Belamcandae 30-40 part; Radix Scutellariae 30-45 part; Rhizoma Cimicifugae 30-40 part; Radix Angelicae Sinensis 30-40 part; Bulbus Fritillariae Cirrhosae 10-20 part; Rhizoma Dioscoreae 15-35 part; Rhizoma Alismatis 20-30 part; Radix Stemonae 20-35 part; Radix Trichosanthis 25-35 part; Fructus Perillae 5-8 part; Flos Daturae 1-3 part; Semen Sinapis Albae 20-30 part; Fructus Schisandrae Chinensis 35-45 part; Poria 20-30 part; Radix Scrophulariae 8-20 part.
3. Chinese medicine composition according to claim 1, is characterized in that, described Chinese medicine composition is prepared from by the crude drug of following weight proportion: Radix Glycyrrhizae 30-50 part; Fructus Aurantii Immaturus 12-25 part; Radix Rehmanniae Preparata 15-35 part; Rhizoma Belamcandae 35-45 part; Radix Scutellariae 30-45 part; Rhizoma Cimicifugae 22-28 part; Radix Angelicae Sinensis 30-40 part; Bulbus Fritillariae Cirrhosae 10-20 part; Rhizoma Dioscoreae 18-30 part; Rhizoma Alismatis 20-30 part; Radix Stemonae 20-35 part; Radix Trichosanthis 25-35 part; Fructus Perillae 5-8 part; Flos Daturae 1-3 part; Semen Sinapis Albae 20-30 part; Fructus Schisandrae Chinensis 35-45 part; Poria 20-30 part; Radix Scrophulariae 8-20 part.
4. Chinese medicine composition according to claim 3, is characterized in that, described Chinese medicine composition is prepared from by the crude drug of following weight proportion: 50 parts, Radix Glycyrrhizae; 25 parts of Fructus Aurantii Immaturuss; 30 parts, Radix Rehmanniae Preparata; 45 parts of Rhizoma Belamcandae; 30 parts of Radix Scutellariae; 25 parts of Rhizoma Cimicifugaes; 40 parts of Radix Angelicae Sinensis; 10 parts of Bulbus Fritillariae Cirrhosae; 30 parts of Rhizoma Dioscoreaes; 30 parts of Rhizoma Alismatis; 20 parts of the Radixs Stemonae; 25 parts of Radix Trichosanthis; 5 parts of Fructus Perillaes; 1 part of Flos Daturae; 30 parts of Semen Sinapis Albaes; 35 parts of Fructus Schisandrae Chinensis; 20 parts, Poria; 12 parts of Radix Scrophulariaes.
5. according to the Chinese medicine composition described in claim 1-4 any one, it is characterized in that: it is the various conventional extract oral medicine dosage form that contains or do not contain pharmaceutic adjuvant.
6. Chinese medicine composition according to claim 5, is characterized in that: described preparation can be tablet, granule, pill, water decoction or capsule.
7. a method of preparing the Chinese medicine composition as described in claim 1-4 any one, it is characterized in that: by formula proportion, taking each herbal medicine, each component is washed respectively, is sterilizing 40-45 minute under 100 ℃, the condition of normal pressure in temperature, be crushed to again 100 object fine powders, mix.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410162808.XA CN103933437A (en) | 2014-04-22 | 2014-04-22 | Traditional Chinese medicine composition for treating asthma and preparation method for same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410162808.XA CN103933437A (en) | 2014-04-22 | 2014-04-22 | Traditional Chinese medicine composition for treating asthma and preparation method for same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103933437A true CN103933437A (en) | 2014-07-23 |
Family
ID=51181493
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410162808.XA Pending CN103933437A (en) | 2014-04-22 | 2014-04-22 | Traditional Chinese medicine composition for treating asthma and preparation method for same |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103933437A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104984054A (en) * | 2015-07-22 | 2015-10-21 | 袁玥 | Traditional Chinese medicine composition for treating asthma |
| CN105106610A (en) * | 2015-08-04 | 2015-12-02 | 安徽谓博中药股份有限公司 | Traditional Chinese medicine composition for treating asthma |
| CN106237199A (en) * | 2016-08-31 | 2016-12-21 | 王平安 | A kind of Chinese medicine composition treating typhoid cough |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1903287A (en) * | 2006-08-03 | 2007-01-31 | 谷瑞起 | Medicine for treating bronchitic asthma and chronic bronchitis and its prepn. method |
| CN102145144A (en) * | 2011-04-06 | 2011-08-10 | 朱新华 | Traditional Chinese medicine preparation for treatment of asthma |
| CN102362935A (en) * | 2011-11-17 | 2012-02-29 | 成都盛尔嘉科技有限公司 | Chinese medicine for treating bronchial asthma |
-
2014
- 2014-04-22 CN CN201410162808.XA patent/CN103933437A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1903287A (en) * | 2006-08-03 | 2007-01-31 | 谷瑞起 | Medicine for treating bronchitic asthma and chronic bronchitis and its prepn. method |
| CN102145144A (en) * | 2011-04-06 | 2011-08-10 | 朱新华 | Traditional Chinese medicine preparation for treatment of asthma |
| CN102362935A (en) * | 2011-11-17 | 2012-02-29 | 成都盛尔嘉科技有限公司 | Chinese medicine for treating bronchial asthma |
Non-Patent Citations (1)
| Title |
|---|
| 张蕴卓等: ""支气管哮喘的中医治疗进展"", 《天津中医药大学学报》, vol. 25, no. 4, 31 December 2006 (2006-12-31) * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104984054A (en) * | 2015-07-22 | 2015-10-21 | 袁玥 | Traditional Chinese medicine composition for treating asthma |
| CN105106610A (en) * | 2015-08-04 | 2015-12-02 | 安徽谓博中药股份有限公司 | Traditional Chinese medicine composition for treating asthma |
| CN106237199A (en) * | 2016-08-31 | 2016-12-21 | 王平安 | A kind of Chinese medicine composition treating typhoid cough |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103536889A (en) | Traditional Chinese medicine decoction for treating senile chronic bronchitis complicated pulmonary emphysema | |
| CN100478020C (en) | Stomatocase treating medicine | |
| CN101647979B (en) | Traditional Chinese medicine for treating bronchial asthma | |
| CN103830636A (en) | Pharmaceutical composition for treating bronchitis and asthma | |
| CN102085346B (en) | Traditional Chinese medicine composition for treating chronic obstructive pulmonary disease | |
| CN103432374A (en) | Medicine for treating pneumonia of pig | |
| CN103933437A (en) | Traditional Chinese medicine composition for treating asthma and preparation method for same | |
| CN103585401A (en) | Traditional Chinese medicine composition for treating bird flu and preparation method therefor. | |
| CN104922346A (en) | Traditional Chinese medicine for treating chronic pharyngitis | |
| CN103623372A (en) | Medicine for treating trachitis | |
| CN102512540A (en) | Chinese medicine composition for treating asthma | |
| CN103495130B (en) | Traditional Chinese medicine composition for treating asthma | |
| CN103977270B (en) | A kind of Chinese medicine treated constipation | |
| CN103816373A (en) | Medicinal liquor for treating rheumatism | |
| CN102716372B (en) | Traditional Chinese medicine composition for curing chronic cough, and preparation method and usage thereof | |
| CN105381291A (en) | Traditional Chinese medicine composition for preventing and treating pneumonia, preparation method and applications thereof | |
| CN104906337B (en) | A kind of Radix Glycyrrhizae pear Bulbus Fritillariae Ussuriensis and preparation method | |
| CN105497738A (en) | Gastroptosis treating traditional Chinese medicine composition | |
| CN103006950A (en) | Traditional Chinese medicine for treating pharyngolaryngitis and preparation process thereof | |
| CN103083524A (en) | Traditional Chinese medicine granules used for treating chicken aspergillosis, and preparation method thereof | |
| CN103041154B (en) | Chinese medicine composition for treatment of cough | |
| CN106215040A (en) | A kind of Chinese medicine composition treating asthma | |
| CN105362596A (en) | Traditional Chinese medicine for treating pulmonary emphysema and preparation method thereof | |
| CN105233162A (en) | Traditional Chinese medicine composition for treating chronic cholecystitis, and preparation method and pharmaceuticals thereof | |
| CN103599341B (en) | A kind of pharmaceutical composition for the treatment of cough with asthma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140723 |
|
| RJ01 | Rejection of invention patent application after publication |